Innophos Holdings Inc (NASDAQ:IPHS) Q4 2016 Sentiment Report

July 18, 2017 - By test

 Innophos Holdings Inc (NASDAQ:IPHS)  Q4 2016 Sentiment Report

Sentiment for Innophos Holdings Inc (NASDAQ:IPHS)

Innophos Holdings Inc (NASDAQ:IPHS) institutional sentiment decreased to 1.06 in Q4 2016. Its down -0.24, from 1.3 in 2016Q3. The ratio turned negative, as 88 institutional investors increased or opened new holdings, while 83 reduced and sold stakes in Innophos Holdings Inc. The institutional investors in our partner’s database now hold: 17.78 million shares, up from 17.78 million shares in 2016Q3. Also, the number of institutional investors holding Innophos Holdings Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 14 Reduced: 69 Increased: 54 New Position: 34.

Innophos Holdings, Inc. is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The company has market cap of $836.89 million. The Firm also provides bioactive mineral and nutritional ingredients. It has a 18.45 P/E ratio. The Company’s divisions include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate & Other.

It closed at $42.97 lastly. It is down 18.50% since July 18, 2016 and is uptrending. It has outperformed by 1.80% the S&P500.

Investors wait Innophos Holdings, Inc. (NASDAQ:IPHS) to report on August, 7. its quarterly earnings Wall Street analysts expect $0.66 earnings per share, up $0.05 or 8.20 % from last year’s $0.61 same quarter earnings. This translates into $12.85 million profit for IPHS giving the stock a 16.28 P/E. This is assuming the current $0.66 EPS is accurate. Innophos Holdings, Inc.’s Wall Street analysts see 11.86 % EPS growth, taking into account the $0.59 EPS reproted in the previous quarter,

Kestrel Investment Management Corp holds 2.39% of its portfolio in Innophos Holdings, Inc. for 122,400 shares. Daruma Capital Management Llc owns 693,169 shares or 2.06% of their US portfolio. Moreover, Ironwood Investment Management Llc has 1.35% invested in the company for 35,425 shares. The Maryland-based Investment Counselors Of Maryland Llc has invested 1.02% in the stock. Heartland Advisors Inc, a Wisconsin-based fund reported 288,836 shares.#img1#

Since January 1, 0001, it had 0 buys, and 1 sale for $676,272 activity.

Innophos Holdings, Inc. (NASDAQ:IPHS) Ratings Coverage

Ratings analysis reveals 50% of Innophos Holdings’s analysts are positive. Out of 2 Wall Street analysts rating Innophos Holdings, 1 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. IPHS was included in 5 notes of analysts from August 24, 2015. The rating was initiated by Sidoti with “Buy” on Thursday, October 20. Sidoti upgraded the stock to “Buy” rating in Friday, May 26 report. The firm has “Sell” rating by Zacks given on Monday, August 24. Sidoti downgraded the shares of IPHS in report on Friday, December 16 to “Neutral” rating. The company was downgraded on Thursday, September 3 by Zacks.

More notable recent Innophos Holdings, Inc. (NASDAQ:IPHS) news were published by: Prnewswire.com which released: “Innophos Unveils “Vision 2022: The Path to Revitalized Growth” Targeting $1.25 …” on April 05, 2017, also Prnewswire.com with their article: “Innophos Holdings, Inc. Appoints Joshua Horenstein As Chief Legal Officer And …” published on September 09, 2016, Prnewswire.com published: “Innophos Holdings, Inc. Appoints Seasoned Global Operations Executive Mark …” on April 27, 2017. More interesting news about Innophos Holdings, Inc. (NASDAQ:IPHS) were released by: Businesswire.com and their article: “Sharon Merrill Associates Announces the Addition of Innophos Holdings Inc. to …” published on June 06, 2017 as well as Prnewswire.com‘s news article titled: “Innophos Holdings, Inc. Reports Third Quarter 2016 Results” with publication date: October 27, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.